Intrahepatic cholestasis after liver transplantation

被引:97
作者
Ben-Ari, Z
Pappo, O
Mor, E
机构
[1] Rabin Med Ctr, Liver Inst, IL-49100 Petah Tiqwa, Israel
[2] Rabin Med Ctr, Dept Med D, IL-49100 Petah Tiqwa, Israel
[3] Rabin Med Ctr, Dept Histopathol, IL-49100 Petah Tiqwa, Israel
[4] Rabin Med Ctr, Dept Transplantat, IL-49100 Petah Tiqwa, Israel
[5] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel
关键词
D O I
10.1053/jlts.2003.50212
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Cholestasis is a common sequela of liver transplantation. Although the majority of cases remain sub,clinical, severe cholestasis may be associated with irreversible liver damage, requiring retransplantation. Therefore, it is essential that clinicians be able to identify and treat the syndromes associated with cholestasis. In this review, we consider causes of intrahepatic cholestasis. These may be categorized by time of occurrence, namely, within 6 months of liver transplantation (early) and thereafter (late), although there may be an overlap in their causes. The causes of intrahepatic cholestasis include ischemia/reperfusion injury, bacterial infection, acute cellular rejection, cytomegalovirus infection, small-for-size graft, drugs for hepatotoxicity, intrahepatic biliary strictures, chronic rejection, hepatic artery thrombosis, ABO blood group incompatibility, and recurrent disease. The mechanisms of cholestasis in each category and the clinical presentation, diagnosis, treatment, and outcome are discussed in detail.
引用
收藏
页码:1005 / 1018
页数:14
相关论文
共 139 条
[1]   Hepatic artery stenosis after liver transplantation - Incidence, presentation, treatment, and long term outcome [J].
Abbasoglu, O ;
Levy, MF ;
Vodapally, MS ;
Goldstein, RM ;
Husberg, BS ;
Gonwa, TA ;
Klintmalm, GB .
TRANSPLANTATION, 1997, 63 (02) :250-255
[2]  
ADAM R, 1991, TRANSPLANT P, V23, P1538
[3]  
AlFaraidy K, 1997, TRANSPLANTATION, V64, P926
[4]   Immunosuppressive drugs, the first 50 years and a glance forward [J].
Allison, AC .
IMMUNOPHARMACOLOGY, 2000, 47 (2-3) :63-83
[5]   VARIABLE EFFECT OF URSODEOXYCHOLIC ACID ON CYCLOSPORINE ABSORPTION AFTER ORTHOTOPIC LIVER-TRANSPLANTATION [J].
ALQUAIZ, MN ;
OGRADY, JG ;
TREDGER, JM ;
WILLIAMS, R .
TRANSPLANT INTERNATIONAL, 1994, 7 (03) :190-194
[6]   Significant increase of Kupffer cells associated with loss of Na+,K+-atpase activity in rat hepatic allograft rejection [J].
Angermuller, S ;
Steinmetz, I ;
Weber, T ;
Czerny, F ;
Hanisch, E ;
Kusterer, K .
TRANSPLANTATION, 1997, 63 (11) :1562-1570
[7]  
APAPTHEODORIDIS GV, 2003, AM J TANSPLANT, V3, P250
[8]   CYTOMEGALOVIRUS-INFECTION PERSISTS IN THE LIVER GRAFT IN THE VANISHING BILE-DUCT SYNDROME [J].
ARNOLD, JC ;
PORTMANN, BC ;
OGRADY, JG ;
NAOUMOV, NV ;
ALEXANDER, GJM ;
WILLIAMS, R .
HEPATOLOGY, 1992, 16 (02) :285-292
[9]   Decision for retransplantation of the liver - An experience- and cost-based analysis [J].
Azoulay, D ;
Linhares, MM ;
Huguet, E ;
Delvart, V ;
Castaing, D ;
Adam, R ;
Ichai, P ;
Saliba, F ;
Lemoine, A ;
Samuel, D ;
Bismuth, H .
ANNALS OF SURGERY, 2002, 236 (06) :713-721
[10]  
BALAN V, 1993, HEPATOLOGY, V18, P1392